No study locations reported - 10 Nov `25Methotrexate delivered through the skin for vitiligo

Methotrexate delivered through the skin for vitiligo

Official title: Methotrexate Iontophoresis Versus Methotrexate 1% Gel on Depigmentation in Vitiligo Patients

Status: Opening soon

Description:

Pharos University in Alexandria plans to enroll about 30 participants. Methotrexate reduces immune activity and is being delivered through or into the skin in this study. Researchers hope it will calm the attack on melanocytes and improve repigmentation. Methotrexate is approved for several cancers and inflammatory diseases; vitiligo would be a new use. Possible effects include skin irritation, mouth sores, nausea, liver problems, low blood counts, and infections. People ages 18 to 40 may qualify. Recruitment has not started, and no locations are listed yet.

Start date: November 10, 2025

Completion date: March 10, 2026

Organizer: Pharos University in Alexandria

Contact: See contacts and locations in the ClinicalTrials.gov record

Link: https://clinicaltrials.gov/study/NCT07208890

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Methotrexate delivered through the skin for vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions

  • Vitiligo and Pregnancy

    VRF Frequently Asked Questions Vitiligo and Pregnancy Pregnancy, treatments, inheritance, fertility and the questions people usually remember to ask five minutes after leaving t...

  • Does halo nevi affect vitiligo development?

    Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...

  • Are there any famous people with vitiligo?

    Many celebrities have dealt with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career. Here are a few courageous famous peo...